Literature DB >> 7574266

Medical management of sinusitis: educational goals and management guidelines. The International Conference on sinus Disease.

J M Gwaltney, J G Jones, D W Kennedy.   

Abstract

The primary goal of sinusitis management is resolution of infection, leading to patency of the ostiomeatal complex. Antibiotics and decongestants are the cornerstones of therapy for acute sinusitis. Diagnosis of acute sinusitis is based on the history and physical findings. Sinusitis is considered to be acute or recurrent acute if infection resolves without residual mucosal damage. Choices for first-line antibiotic therapy include adequate dosages of trimethoprim-sulfamethoxazole, loracarbef, and amoxicillin-clavulanate. Decongestants and mucoevacuants may reduce tissue edema, facilitate drainage, and maintain ostial patency. Topical corticosteroids are useful additional therapy in allergic rhinosinusitis and as an aid in the long-term management of chronic sinusitis. Parenteral corticosteroids have no role in first-line management of acute or recurrent acute sinusitis.

Entities:  

Mesh:

Year:  1995        PMID: 7574266

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol Suppl        ISSN: 0096-8056


  12 in total

1.  Economic evaluation of antibacterials in the treatment of acute sinusitis.

Authors:  C Laurier; J Lachaine; M Ducharme
Journal:  Pharmacoeconomics       Date:  1999-01       Impact factor: 4.981

2.  [Rhinosinusitis guidelines--unabridged version: S2 guidelines from the German Society of Otorhinolaryngology, Head and Neck Surgery].

Authors:  B A Stuck; C Bachert; P Federspil; W Hosemann; L Klimek; R Mösges; O Pfaar; C Rudack; H Sitter; M Wagenmann; R Weber; K Hörmann
Journal:  HNO       Date:  2012-02       Impact factor: 1.284

3.  [Rhinosinusitis guidelines of the German Society for Otorhinolaryngology, Head and Neck Surgery].

Authors:  B A Stuck; C Bachert; P Federspil; W Hosemann; L Klimek; R Mösges; O Pfaar; C Rudack; H Sitter; M Wagenmann; K Hörmann
Journal:  HNO       Date:  2007-10       Impact factor: 1.284

Review 4.  [Sinusitis. An illness to be taken seriously].

Authors:  J Pade
Journal:  HNO       Date:  2005-05       Impact factor: 1.284

5.  The development and validation of an instrument to assess acute sinus disease in children.

Authors:  J M Garbutt; E F Gellman; B Littenberg
Journal:  Qual Life Res       Date:  1999-05       Impact factor: 4.147

6.  The Microbiology and Management of Acute and Chronic Rhinosinusitis.

Authors:  James A. Hadley
Journal:  Curr Infect Dis Rep       Date:  2001-06       Impact factor: 3.725

Review 7.  World Trade Center Cough Syndrome and its treatment.

Authors:  David J Prezant
Journal:  Lung       Date:  2007-11-20       Impact factor: 2.584

8.  Cefprozil versus Cefuroxime Axetil in the Treatment of Acute Sinusitis.

Authors:  E R Brankston; H S Conter; R Corriveau; J M Martel; C Laroche; R Roy; C Savard; D Roy; R Kelly; P Forget; M Rivard; F Boulerice
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

9.  Induction of B7-H1 and B7-DC expression on airway epithelial cells by the Toll-like receptor 3 agonist double-stranded RNA and human rhinovirus infection: In vivo and in vitro studies.

Authors:  Lowella Heinecke; David Proud; Scherer Sanders; Robert P Schleimer; Jean Kim
Journal:  J Allergy Clin Immunol       Date:  2008-04-18       Impact factor: 10.793

10.  Numerical simulation and nasal air-conditioning.

Authors:  Tilman Keck; Jörg Lindemann
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2011-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.